1-3 of 3
Francis Lee, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Dasatinib Induces a Rapid, Dose-Controllable Mobilization of Cytotoxic Lymphocytes: A Novel Immunomodulatory Effect Associated with Prolonged Therapy Responses In Advanced Leukemia.

Satu Mustjoki, MD, PhD, Philippe Rousselot, MD, PhD, Sari Jalkanen, Msc, Anna Kreutzman, MSc, Teresa Melo, MD, Anna-Maria Lahesmaa, MSc, Sampsa Hautaniemi, PhD, Mathieu Molimard, MD, PhD, Richard Smykla, PhD, Francis Lee, PhD, Jukka Vakkila, MD, PhD, Kimmo Porkka, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 1204.
https://doi.org/10.1182/blood.V116.21.1204.1204
Published: 2010
Journal Articles

Significant Activity of Dasatinib in CLL Demonstrated by Ex-Vivo Assay.

Darren S. Sigal, MD, Jorge Nieva, MD, Jonathan Diver, PhD, Elisa Romeo, PhD, Francis Lee, PhD, Alan Saven, MD
Journal: Blood
Blood (2007) 110 (11): 4197.
https://doi.org/10.1182/blood.V110.11.4197.4197
Published: 2007
Journal Articles

Constitutive Activation of SRC-Family Kinases in Chronic Myelogenous Leukemia Patients Resistant to Imatinib Mesylate in the Absence of BCR-ABL Mutations: A Rationale for Use of SRC/ABL Dual Kinase Inhibitor-Based Therapy.

Nicholas J. Donato, PhD, Ji Wu, MD, Ling-Yuan Kong, MD, PhD, Feng Meng, MD, Francis Lee, PhD, Moshe Talpaz, MD
Journal: Blood
Blood (2005) 106 (11): 1087.
https://doi.org/10.1182/blood.V106.11.1087.1087
Published: 2005